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Abstract
The actions of environmental toxicants and relevant mixtures in promoting the epigenetic transgenerational inheritance of
ovarian disease was investigated with the use of a fungicide, a pesticide mixture, a plastic mixture, dioxin and a
hydrocarbon mixture. After transient exposure of an F0 gestating female rat during embryonic gonadal sex determination,
the F1 and F3 generation progeny adult onset ovarian disease was assessed. Transgenerational disease phenotypes
observed included an increase in cysts resembling human polycystic ovarian disease (PCO) and a decrease in the ovarian
primordial follicle pool size resembling primary ovarian insufficiency (POI). The F3 generation granulosa cells were isolated
and found to have a transgenerational effect on the transcriptome and epigenome (differential DNA methylation).
Epigenetic biomarkers for environmental exposure and associated gene networks were identified. Epigenetic
transgenerational inheritance of ovarian disease states was induced by all the different classes of environmental
compounds, suggesting a role of environmental epigenetics in ovarian disease etiology.
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Introduction
Environmental exposures during fetal and early postnatal
development can lead to an increased incidence of later life
adult-onset diseases [1,2,3,4]. Such environmental factors include
nutritional abnormalities, stress and exposure to toxicants.
Examples include fetal exposures to plasticizers such as bisphenol
A leading to immune abnormalities [5], maternal smoking leading
to increased pulmonary disease in adulthood [6], nutrition defects
leading to hypertension in offspring [7,8] and therapeutic drug
exposure leading to vascular defects [9]. In addition to these direct
effects of early life exposure on adult onset disease, environmental
factors have been shown to affect the next F2 generation
[8,10,11,12]. The subsequent generations transgenerational in-
heritance of epigenetic changes in the genome now provides an
additional molecular mechanism, along with classic induction of
genetic mutations, for the germ line transmission of environmen-
tally induced phenotypic change [2,13,14].
Effects on the F1 and F2 generation can be due to direct
multigenerational exposure to the environmental factor [13,15]. If
a gestating female is defined as the F0 founder generation, then the
fetal offspring are the F1 generation, and the germ cells present in
those developing fetuses will eventually become the eggs or sperm
that would form the F2 generation. An environmental exposure of
an F0 generation gestating female directly exposes both the F1
generation fetuses and the germ cells present in those fetuses that
will generate the F2 generation [2,13,15]. The subsequent F3
generation would be the first generation that would not have been
directly exposed to the environmental factor. Therefore, effects on
the F1 and F2 generation can be due to direct exposure and so
should be considered multigenerational effects [13]. In contrast, a
transgenerational effect following exposure of a F0 generation
gestating female is defined as an effect seen in the F3 or later
generations [15]. Transgenerational phenomena by definition do
not involve direct exposure and have been shown to involve
epigenetic changes induced in the germ line [16,17,18,19].
The initial report of epigenetic transgenerational inheritance of
adult onset disease was from gestating female rats exposed to the
fungicide vinclozolin, in which F3 generation male offspring
showed defects in sperm production [16,20]. Transgenerational
effects have also been reported after exposure of gestating rats to
bisphenol A (BPA), where decreased fertility was seen in the F3
generation males [21]. Decreased fertility was also seen in F3 and
F4 generation female mice after the gestating F0 generation was
exposed to dioxin [22]. Similarly in mice, male F3 generation
offspring showed changes in the methylation pattern of imprinted
genes in sperm following exposure of the gestating F0 generation
female to the agricultural fungicide vinclozolin [23]. Recently, a
number of different exposures to environmental toxicants includ-
ing BPA, phthalates, dioxin, pesticide, DEET and jet fuel
hydrocarbons were found to promote epigenetic alterations in
sperm and transgenerational inheritance of reproduction defects
[19]. Therefore, a number of different environmental toxicants
and other factors such as nutrition [4] can promote epigenetic
transgenerational inheritance of adult onset disease.
In women, adult-onset diseases of the ovary that can dramat-
ically affect fertility are primary ovarian insufficiency and
polycystic ovarian disease. Primary ovarian insufficiency (POI) is
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pool of oocytes (eggs) that appears intrinsic to the ovary, and
induction of menopause prior to age 40 [24]. This is associated
with decreased estrogen and elevated gonadotropin levels in the
blood. POI affects about 1% of women [25,26,27]. A reduced
primordial follicle pool size correlated with POI has been shown in
sheep and primates to also associate with polycystic ovarian
disease [28,29]. POI is often thought to have a genetic basis since
chromosomal abnormalities and single gene mutations are
associated with a percentage of POI cases. However, only a
minority (4–20%) of human cases can be ascribed a genetic basis
[26,27,30,31,32,33,34,35,36].
Polycystic ovarian (PCO) disease or polycystic ovary syndrome
(PCOS) is a common endocrine disorder that affects 6–18% of
women [37,38,39,40,41,42]. It is characterized by infrequent
ovulation or anovulation, high androgen levels in the blood, and
the presence of multiple persistent ovarian cysts [43]. PCOS
patients often show insulin resistance and a heightened risk for
diabetes [44]. Current thought on the etiologies that lead to
development of PCOS is that there are both genetic and
environmental causal factors. A genetic predisposition in an
individual may combine with an early-life environmental impact
such as fetal stress or increased androgens in utero and lead to
development of PCOS in adulthood [44,45,46]. Fetal or early
postnatal exposure to androgens (e.g. di-hydrotestosterone) has
been shown to promote PCO and associated clinical parameters
(e.g. metabolic abnormalities, adiposity and endocrine abnormal-
ities) in rats, mice and sheep [47,48,49]. Therefore, the rodent
PCO model has many of the same clinical correlations that are
seen with PCOS in humans. Sequence variations in several genes
have been associated with PCOS [46,50,51], although at very low
frequency and none are highly predictive. Epigenetic abnormal-
ities such as those associated with non-random X-chromosome
inactivation have also been linked to PCOS [51,52,53,54]. Several
diseases are now known to have an important epigenetic
component, such as allergies [55], hepatic cancer [56], gastric
cancer [57], asthma [58], colorectal cancer [59], prostate cancer
[60], HIV latency [61] and psychiatric disorders [62]. The current
study was designed to investigate the role of environmental
epigenetics in ovarian disease.
A rat model is used to evaluate whether adult onset ovarian
diseases are induced transgenerationally after exposure of a
gestating F0 generation female to known environmental toxicants.
The exposures are during days 8–15 of fetal development, which is
the time of gonadal sex determination. The exposure compounds
were: 1) Vinclozolin, an agricultural fungicide previously shown to
cause transgenerational epigenetic disease [13,20,23]; 2) A mixture
of permethrin, the most commonly used human insecticide shown
to have minor toxicologic effects in mammals [63] and DEET, an
insect repellent reported to have negligible toxic effects [63]; 3) A
plastic mixture of bisphenol A (BPA), dibulylphthalate (DBP) and
bis(2-ethylexyl)phthalate (DEHP), all plasticizer chemicals that
commonly appear together from plastics with in vitro and in vivo
toxic effects [64]; 4) Dioxin (TCDD), a by-product of some
commercial chemical syntheses that has been shown to induce
adult-onset diseases including premature acyclicity [65,66]; and 5)
Jet fuel (JP8), a hydrocarbon mixture (i.e. C3-.C20) often used for
dust control on road surfaces, with known toxicologic effects
[67,68], but is not known to induce reproductive defects [69]. The
United States Department of Defense assisted in the selection of
these toxicants and mixtures due to their relevance for exposures
anticipated for military personnel. The plastic mixture included
the three common toxicants present in heated bottled water, the
pesticide mixture is the most common used in humans and the
hydrocarbon mixture (i.e. jet fuel JP8) is commonly used in dust
control on road surfaces. All of the above environmental toxicants
have been implicated in inducing transgenerational disease
phenotypes [13,19,21,22]. The current study used pharmacolog-
ical doses and administration to assess potential transgenerational
actions on ovarian disease and should not be considered a risk
assessment analysis. Future studies are now needed to do
environmental risk assessment, based on the observations of the
current studies.
The adult F3 generation females from each exposure lineage
group were examined for the incidence of ovarian diseases similar
to primary ovarian insufficiency and polycystic ovarian disease.
The human ovarian diseases POI and PCOS have numerous
other clinical conditions associated with them such as endocrine
abnormalities and glucose intolerance. Therefore, the rat ovarian
abnormalities/disease cannot be directly correlated to the clinical
aspects of human ovarian disease, but do share the majority of
morphological changes. In order to gain insight into possible
cellular and molecular mechanisms involved in ovarian disease
development, the granulosa cells from F3 generation vinclozolin
and control lineage animals were evaluated for changes to their
transcriptome and epigenome (DNA methylation pattern). All the
primary cell types of an ovarian follicle such as the oocyte, theca
cells and granulosa cells are anticipated to develop a transgener-
ationally altered transcriptome and epigenome [14], and so will
participate in the adult onset disease development. The granulosa
cell was selected to provide the proof of concept that such an
alteration in genome activity could develop. Future studies will
investigate the other cell types. The capacity of vinclozolin to
directly induce oocyte loss in ovaries was also examined to clarify
how F1 generation effects may develop. Observations demonstrate
that the environmental toxicants examined induced transgenera-
tional ovarian adult-onset disease, and suggest that primary
ovarian insufficiency and polycystic ovarian disease can have an
epigenetic transgenerational etiology.
Results
Transgenerational Ovarian Disease
Gestating female rats, designated as F0 generation animals,
were treated by intraperitoneal injection daily from E8 (post
conception gestational day 8) through E14. The F0 generation
female rats received one of five different treatments as described in
Methods: Vinclozolin, Pesticide (includes permethrin and DEET),
Plastics (includes BPA, DBP and DEHP), Low-dose Plastics (50%
of Plastics dose), Dioxin, Hydrocarbon (Jet fuel JP8), or DMSO
vehicle as Control. The F1 generation offspring were bred to
others of the same treatment group to produce an F2 generation,
and F2 generation animals were similarly bred to produce an F3
generation (see Methods). No sibling or cousin breedings were
used to avoid any inbreeding artifacts. Only the original F0
generation gestating female rats received the treatment exposures.
Female rats from the F1 and F3 generations were kept until one
year of age and then sacrificed. Ovaries were removed, fixed,
sectioned and stained for histologic examination.
The number of oocytes (i.e. eggs) present in the ovaries was
determined by counting follicles. Each ovarian follicle is composed
of an oocyte surrounded by a layer of granulosa cells, a basement
membrane and outer layers of thecal cells. Primordial follicles are
in an arrested state of development and contain a single layer of
squamous flattened granulosa cells. Developing follicles have
multiple layers of proliferating granulosa cells and an increase in
the oocyte diameter. Later in follicle development a fluid-filled
antrum forms [70,71,72,73]. In the F1 and F3 generation, ovarian
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mine the number of primordial follicles, pre-antral developing
follicles and antral developing follicles as described in Methods
[74].
In F1 generation ovaries there was a marked and statistically
significant (p,0.001) reduction in the number of primordial
follicles in all exposure groups compared to ovaries from the
vehicle-treated control lineage (Fig. 1). This indicates that the
female fetuses exposed to these compounds during gonadal sex
determination all have a decrease in their resting pool of
primordial follicles. There was no change in the number of pre-
antral developing follicles or antral developing follicles, except in
the case of females of the vinclozolin-treated lineage. F1
vinclozolin group ovaries had significantly (p,0.05) fewer
preantral developing follicles compared to controls (Fig. 1). This
effect of the exposures on the F1 generation is attributed to direct
fetal ovarian exposure to the treatments.
Since treatment with environmental toxicants resulted in fewer
oocytes being present in F1 generation adult ovaries compared to
controls, an experiment was performed to assess if vinclozolin
could act directly on ovaries to reduce oocyte number. Ovaries
from four-day old rats, containing predominately primordial
follicles, were placed into a whole-ovary culture system (see
Methods) and treated in vitro for ten days with varying
concentrations of vinclozolin. Treatment with 500 mM vinclozolin
did result in a decrease (p,0.05) in oocyte number compared to
controls (Fig. 2). The 200 mM and lower doses of vinclozolin did
not significantly reduce oocyte number. Therefore, direct actions
of vinclozolin on the F1 generation fetal gonad have the potential
to reduce follicle numbers if the dose is sufficient.
Figure 1. Follicle numbers and development. A) Number of primordial, preantral, and antral follicles per section in F1 generation ovaries. N=9
animals per treatment group. B) Number of follicles per section in F3 generation ovaries. N=9 animals per treatment group. Asterisks indicate groups
significantly (*p#0.05, ***p#0.005) different than controls of their own follicle type by ANOVA followed by Dunnet’s post-hoc test. C) H and E stained
section of F3 generation control ovary showing several primordial follicles (arrows). D) H and E stained section of F3 generation vinclozolin lineage
ovary without visible primordial follicles. Asterisk indicates a developing secondary follicle. Scale bar=40 mm.
doi:10.1371/journal.pone.0036129.g001
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significant (p,0.001) reduction in the number of primordial
follicles in all treatment groups, compared to controls (Fig. 1).
Since none of these F3 generation animals were themselves
exposed to the treatment compounds, this reduction in oocyte
number is a transgenerational effect. There was no change in the
number of preantral developing or antral developing follicles for
any exposure lineage group compared to control lineage animals.
Therefore, all the exposure groups examined induced a significant
transgenerational decline in the primordial follicle pool size. For
the purposes of this study, the ovaries of an animal were classified
as having ‘‘disease’’ if the ovary primordial follicle numbers were
$2 standard deviations less than that seen in controls. The
incidence of the follicle pool disease was 33–60% across treatment
groups.
Polycystic ovarian (PCO) disease is a common disease in
humans, so ovaries from F1 and F3 generation animals were
evaluated for the presence of cystic structures. Ovarian cysts were
defined and categorized as either small or large cysts, as described
in Methods. Interestingly, an increase in the number of both small
and large cysts were seen most often in F3 generation ovaries from
exposure lineages, rather than in F1 generation ovaries (Fig. 3). An
increase (p,0.01) in small cysts was seen in all F3 generation
treatment groups, compared to controls. However, in the F1
generation only the low-dose plastics, jet fuel hydrocarbons and
vinclozolin lineage ovaries showed an increase (p,0.05) in small
cysts. An increase in large cysts was observed in the F3 generation
ovaries of the vinclozolin, pesticide, low-dose plastics and jet fuel
treatment groups (Fig. 3). However, in F1 generation ovaries only
the low-dose plastics showed an increase in the incidence of large
cysts compared to controls. These results indicate that develop-
ment of ovarian cysts occurs more often in the F3 generation,
which demonstrates a transgenerational effect of the toxicant
exposures. The large cysts observed in these ovaries often were
lined with a sporadic single layer of epithelial granulosa cells and
were surrounded by a band of theca cells (Fig. 3F). This is
consistent with these large cysts being derived from antral follicles.
However, some large cysts and associated cells were morpholog-
ically identified as being from corpora lutea [19]. These luteal cysts
were present frequently in the F3 generation jet fuel hydrocarbon
exposure lineage ovaries, Figure 3.
The number of healthy-looking large antral follicles was not
found to be different between exposure and control groups in
either the F1 or F3 generation ovaries (Fig. 4A & B). The
exception was that there were significantly fewer (p,0.05) large
antral follicles in the F3 pesticide-lineage ovaries. Therefore, the
antral follicle development process appears relatively normal in the
F1 and F3 generation females independent of exposure lineage.
Previous studies have demonstrated that negligible endocrine
abnormalities are detected in 120-day-old F3 generation female
rats following exposure to any of the toxicants studied [19,75].
PCO has previously been associated with an increase in androgen
serum levels which is due to the highly steroidogenic theca cells of
the cysts. Theca cells primarily produce androstenedione so the
serum androstenedione levels in the F3 generation 1-year-old
females were examined. Preliminary studies show that the F3
generation control lineage had 4763 pg/mL and the vinclozolin
lineage had 177682 pg/mL serum androstenedione. Therefore,
the androgen levels were increased in the F3 generation
vinclozolin lineage females that had the PCO disease. This
increase in androgen levels requires further investigation as do the
other associated clinical conditions of glucose intolerance,
abnormal adiposity and hyperinsulemia.
Transgenerational Granulosa Cell Transcriptome
Previous studies demonstrated the vinclozolin induced epige-
netic transgenerational inheritance of adult onset disease involving
epigenetic modifications of the sperm [16] and heritable pheno-
types through the paternal lineage [20]. The only cell that can
transmit an altered epigenome between generations is the germline
[13], however, all the cells derived from this sperm will have an
altered epigenome transcriptome [14]. In order to see if
transgenerational changes in gene expression are apparent in
ovarian follicle cells of the exposure lineage females, the
transcriptomes of granulosa cells from control and vinclozolin
lineage ovaries were compared. Granulosa cells were collected
from pre-ovulatory follicles of five-month old F3 generation
vinclozolin and control lineage ovaries as described in Methods.
Messenger RNA was isolated from the granulosa cells of each
animal (n=24) and RNA from four animals of the same treatment
group were pooled to create three different pooled samples from
each of the two treatment groups. Three F3 generation
vinclozolin-lineage and three control-lineage mRNA pooled
samples were used in a microarray analysis as described in
Methods to evaluate alterations in gene expression. The analysis
demonstrated that 523 genes were differentially expressed between
control and vinclozolin lineage F3 generation granulosa cells
(Table S1). The number of differentially expressed genes in each of
several functional gene categories is shown in Figure 5 with the
number of up-regulated and down-regulated genes indicated.
Many of the differentially expressed genes were identified as
contributing to metabolism or signaling processes. The complete
list of differentially expressed genes is functionally categorized and
presented in Table S1.
A table of cellular pathways and processes impacted by the
genes differentially expressed in vinclozolin lineage F3 generation
granulosa cells is presented (Table 1). In Figure S2, two of the
more heavily impacted cellular pathways are shown, PPAR
signaling and steroid biosynthesis, with the differentially expressed
genes highlighted. These data indicate that gene expression is
altered transgenerationally in granulosa cells and that specific
physiological processes may be affected by these changes.
Additional bioinformatic analyses examined the functional rela-
Figure 2. Number of oocytes per ovarian cross-section in
ovaries taken from 4-day old rats and cultured whole for 10
days in the presence of different concentrations of vinclozolin.
Data are from five different experiments performed in replicate.
Asterisks indicate groups significantly (*p#0.05) different than controls
by ANOVA followed by Dunnet’s post-hoc test.
doi:10.1371/journal.pone.0036129.g002
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identified. An unbiased literature based network analysis was
performed as described in Methods to determine which genes are
functionally linked with respect to binding, signaling or regulation.
This created a gene network of direct connections as shown in
Figure 6. Some genes show significant functional connections to
others, such as ESR1, MMP2 and CXCL12. Such highly
connected genes may play important regulatory roles in these F3
generation granulosa cells and in the development of ovarian
disease states. Therefore, a transgenerational change in the
granulosa cell transcriptome was identified that may be in part a
causal factor in the molecular etiology of the transgenerational
ovarian disease. Further analysis of the 523 genes with
transgenerational alterations in gene expression identified previ-
ously known genes involved in ovarian disease and more
specifically polycystic ovarian disease. A total of 30 genes were
found to be related to ovarian disease and 5 directly related to
PCO disease, Figure 7. Therefore, genes known to have a
relationship with PCO and ovarian disease were shown to have
altered expression. The potential role of the transgenerational
change in the granulosa cell epigenome to promote this
transcriptome alteration is described below.
Transgenerational Granulosa Cell Epigenome
As previously described [13,16,20], an epigenetic transgenera-
tional alteration of the sperm in vinclozolin lineage F3 generation
animals can promote a transgenerational change in the epigenome
unique to each cell type in all somatic cells derived from this germ
line [14,76]. The F3 generation vinclozolin lineage alterations in
differentially DNA methylated regions (DMR) in the granulosa
cells was investigated. For this, a methylated DNA immunopre-
cipitation (MeDIP) procedure was used, followed by comparative
Figure 3. Ovarian cysts. Number of small (50–250 mm) cysts per section in F1 (A) and F3 (B) generation ovaries. Number of large (.250 mm) cysts
per section in F1 (C) and F3 (D) generation ovaries. N=9 animals per treatment group. Asterisks indicate groups significantly (*p#0.05, **p#0.01,
***p#0.005) different than controls by ANOVA followed by Dunnet’s post-hoc test. E) H and E stained section of F3 ovary showing small cysts. F) H
and E stained F3 ovary showing a large cyst. G) Expanded view of small and large cysts.
doi:10.1371/journal.pone.0036129.g003
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termed an MeDIP-Chip assay, as previously described [16]. The
MeDIP-Chip analysis of the differential DNA methylation
between control and vinclozolin lineage F3 generation granulosa
cells identified 43 DMR with a statistical significance p.10
27,
Table 2. The chromosomal locations of all the DMR are presented
in Figure 8 and indicates most autosomes are involved. A
comparison of the 43 DMR identified with the 523 differentially
expressed granulosa cell genes demonstrated only 1 gene promoter
with overlap (Plekhm1). Analysis of the probability for a random
overlap between the 43 DMR and the 523 differentially expressed
genes indicated that an overlap of 1.47 genes would be expected.
Therefore, the one gene overlap is likely not significant. The vast
majority of differentially expressed genes did not have a DMR
present in their promoters. Further analysis using statistically
significant over represented clusters of differentially expressed
genes identified 26 clusters from 2–5 Mbase size that had 4 to 9
genes each, Table S2. An overlap of these regulated gene clusters
with the DMR identified 3 overlapped clusters, Figure 8. These 2–
5 Mbase regions we refer to as potential Epigenetic Control
Regions (ECR). The hypothesis is that the epigenetic regulatory
site (e.g. DMR) regulates distally the expression of genes within
this ECR. This is likely mediated through non-coding RNA,
similar to what is seen for imprinting control regions (ICR)
Figure 4. Large antral follicles. A) Number of large antral follicles per section in F1 generation ovaries. B) Number of large antral follicles per
section in F3 generation ovaries. N=9 animals per treatment group. Asterisks indicate groups significantly (*p#0.05) different than controls by
ANOVA followed by Dunnet’s post-hoc test.
doi:10.1371/journal.pone.0036129.g004
Figure 5. Number of genes with mRNA expression levels significantly different between Control and Vinclozolin-lineage F3
generation granulosa cells. Genes are placed into functional categories.
doi:10.1371/journal.pone.0036129.g005
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RNA in the rat have been characterized, but of the 20
characterized 3 (NEAT1(chr1:204.8), khps1a (chr10:103.4),
Zfhx2as (chr15:31.8)) had an overlap with the ECR identified.
Further analysis of the rat lncRNA is needed before future
correlation with the ECR can be made. The ECR provide one
explanation for how a limited number of DMR can potentially
control a large number of differentially regulated genes. The
locations of the potential ECR are included in Figure 8 to correlate
with the DMR identified.
Previously the sperm DMR identified in vinclozolin lineage F3
generation animals was reported [16]. An overlap of these sperm
DMR with the current granulosa cell DMR demonstrated no
overlapped sites. The lack of DMR overlap demonstrates different
transgenerational epigenomes between the sperm and granulosa
cell. It is anticipated that the cascade of epigenetic and
transcriptome steps to achieve a differentiated somatic cell will
lead to very distinct cell specific epigenomes with minimal overlap
with the germ line [14]. Therefore, observations demonstrate that
the F3 generation vinclozolin lineage granulosa cells have
transgenerational changes in the epigenome that correlate with
transgenerational changes in the transcriptome that in turn are
proposed to have a role in the induction of the transgenerational
ovarian disease. All the other cell types in the ovary (e.g. oocyte,
theca cells, ovarian stromal cells) are also expected to have
transgenerational epigenome and transcriptome changes that will
also contribute to ovarian disease. The granulosa cell observations
provide the proof of concept that the transgenerational disease
phenotype develops from the transgenerational effects of the
altered epigenome on somatic cell transcriptomes.
Discussion
The most common human diseases of the ovary are primary
ovarian insufficiency and polycystic ovarian disease. These
conditions can cause infertility and increase the risk for other
related health issues. Primary ovarian insufficiency affects about
1% of women, while polycystic ovarian disease affects as many as
18% of women [25,26,27,37,38,39,40,41,42,44]. In the current
study, F0 generation gestating female rats were exposed to various
environmental compounds during fetal gonadal sex determination
followed by F1 and F3 generation progeny being examined for
ovarian histology. Ovarian abnormalities resembling the follicle
pool depletion that precedes primary ovarian insufficiency and the
cyst formation of polycystic ovarian disease were observed
transgenerationally at an increased rate in the F3 generation
exposure lineage animals. Molecular studies were performed
comparing F3 generation control to vinclozolin lineage animals
that indicated that there were transgenerational alterations in the
epigenome and transcriptome of granulosa cells from ovarian
follicles. These results raise the possibility that the disease etiology
may in part be a result of exposure to environmental toxicants that
promote epigenetic transgenerational inheritance of ovarian
disease.
The analysis of ovarian follicle counts showed that there were
significantly fewer oocytes in the ovaries of all of the exposure
lineage females. Mean decreases in primordial follicle counts of
35% to 60% were seen in both the F1 and the F3 generation
animals (Fig. 1). Since F1 generation animals were directly
exposed to the environmental compounds in utero when the F0
gestating females were exposed, the F1 generation decrease in
oocyte number compared to controls can be due to direct
exposure of the follicles to the compounds. This possibility was
tested using an organ culture system in which ovaries isolated from
neonatal rats were treated with varying doses of vinclozolin or
were left untreated as controls. A dose of 500 mM vinclozolin
resulted in significantly fewer oocytes, while 200 mM and lower
concentrations were not significantly different from controls
(Fig. 2). F0 generation gestating female rats were treated with
100 mg/kg vinclozolin, which converts to approximately a
350 mM dose (assuming a whole-body volume of distribution).
So it is conceivable that germ cells/oocytes could be lost in the F1
females when their F0 generation mothers are treated with
vinclozolin. The epigenetic transgenerational inheritance of adult
onset disease induced by the toxicants used in previous studies
[19,78] demonstrates that the compounds or their metabolites pass
the placenta to reach the fetus. Direct exposure to several of the
toxicants used in this study has previously been shown to affect
Table 1. Physiological Pathway Enrichment.
Pathway Name
# Input Genes
in Pathway
Impact
Factor**
PPAR signaling pathway 11 17.0
Phagosome 11
Cell adhesion molecules (CAMs) 10 10.3
Endocytosis 10
Steroid biosynthesis 9
Peroxisome 8
Antigen processing and presentation 8 38.5
Leukocyte transendothelial migration 8 8.9
Fatty acid metabolism 6
Valine, leucine and isoleucine degradation 6
Spliceosome 6
Lysosome 6
Fc gamma R-mediated phagocytosis 6
Regulation of actin cytoskeleton 6 4.7
Cysteine and methionine metabolism 5
Glutathione metabolism 5
Glycerophospholipid metabolism 5
Biosynthesis of unsaturated fatty acids 5 10.2
MAPK signaling pathway 5 2.9
Neuroactive ligand-receptor interaction 5 1.5
Focal adhesion 5 5.0
Purine metabolism 4
Lysine degradation 4
Phenylalanine metabolism 4
Sphingolipid metabolism 4
Base excision repair 4 7.7
Calcium signaling pathway 4 4.4
Adherens junction 4 7.7
Tight junction 4 5.7
Complement and coagulation cascades 4 7.2
Jak-STAT signaling pathway 4 3.8
Pathways in cancer 4 2.3
Using 523 differentially expressed genes (F3 vinclozolin vs. control granulosa) in
KEGG pathway database.
**Calculated by Pathway Express to estimate importance of these genes to
pathway.
doi:10.1371/journal.pone.0036129.t001
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been shown to decrease the pool of primordial follicles and
increase the incidence of ovarian cyst formation in rat ovaries,
similarly to results of the current study [79,80]. Exposure to the
plastic phthalate DEHP was shown to inhibit steroidogenesis in rat
granulosa cells [81], and to impair oocyte growth and ovulation in
zebrafish [82]. Female rats treated with dioxin both during fetal
development and after birth were reported to have a premature
cessation of reproductive cycles as they aged [65]. However, these
direct exposure effects cannot explain the significant decrease in
oocyte number seen in F3 generation exposure lineage females. F3
generation females were not directly exposed to the environmental
compounds, which suggests a potential epigenetic transgenera-
tional inheritance molecular mechanism.
Primary ovarian insufficiency in humans is characterized by an
early loss of ovarian follicles and onset of menopause. This can
occur when the pool of oocytes in the ovary is depleted to less than
1% of the amount present at puberty, as occurs with menopause
[83,84]. The major physiological parameter of POI is the loss of
the primordial follicle pool. In the current study, F1 and F3
treated-lineage groups of animals showed a 35–60% decrease in
primordial follicle numbers compared to age-matched one-year-
old controls. Approximately 45% of all the exposure lineage F3
generation females developed follicle pool depletion. Normal
female rats usually stop cycling and enter reproductive senescence
at 15–18 months of age. Other studies have shown that
experimental depletion of oocyte numbers in rodents leads to an
early loss of reproductive cycles [85,86,87]. Therefore, it is
expected that animals from toxicant exposure lineages with follicle
pool depletion would have a higher incidence of premature
reproductive senescence (e.g. POI), but this remains to be
investigated.
Polycystic ovarian disease is characterized by multiple persistent
ovarian cysts [43]. In the current study increased numbers of
ovarian cysts were seen in all the treated-lineage groups compared
to the control lineage groups (Fig. 3). Interestingly, this effect was
much more pronounced in the transgenerational F3 animals than
in the directly exposed F1 generation. This suggests that the PCO
disease identified may be due primarily to epigenetic transgenera-
tional mechanisms and not to direct exposure. In addition, PCO
disease was primarily observed in the 1 year old animals and not in
young adults of 120 days of age [19], which is similar to what is
observed in humans. An increase in circulating androstenedione
was observed in the F3 generation vinclozolin lineage females that
had PCO, similar to the clinical phenotype in women with PCO.
Interestingly, research has shown that androstenedione levels are
also increased in animals with follicle pool depletion [88]. The
large cysts found in environmental exposure lineage females
(vinclozolin, pesticide, jet-fuel and low-dose plastics groups) often
had a negligible layer of epithelial/granulosa cells lining the cavity
and only a stromal/thecal layer surrounding the cyst. These
resemble the follicular cysts in PCOS patients [89,90,91].
Figure 6. Gene network of known relationships among those genes found to be differentially expressed in Control compared to
Vinclozolin-lineage F3 generation granulosa cells. Network is derived from an un-biased search of literature using Pathway Studio
TM. Node
shapes code: oval and circle – protein; diamond – ligand; irregular polygon – phosphatase; circle/oval on tripod platform – transcription factor; ice
cream cone – receptor. Red color represents up-regulated genes, blue color – down-regulated genes, grey rectangles represent cell processes; arrows
with plus sign show positive regulation/activation, arrows with minus sign – negative regulation/inhibition. Grey arrows represent regulation, lilac –
expression, green – promoter binding, olive – protein modification.
doi:10.1371/journal.pone.0036129.g006
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PLoS ONE | www.plosone.org 8 May 2012 | Volume 7 | Issue 5 | e36129Luteal cysts were found only in the jet-fuel exposure lineage
animals. These are cysts thought to form in the center of corpora
lutea and are characterized by their surrounding band of luteal
cells. This finding suggests that treatment with the different
environmental toxicants can result in different transgenerational
phenotypes. In contrast, all the different toxicant treatments
resulted in the same increase in small ovarian cysts and in the same
decrease in the primordial follicle pool. This is the case even
though the different environmental exposures used are chemically
dissimilar and would be expected to act through different signaling
mechanisms. Observations suggest that some physiological pro-
cesses in the ovary may be more prone to dys-regulation,
independent of the environmental insult. For example, the
complex signaling network that maintains primordial follicles
and their oocytes in an arrested state [70,74,92,93] may be
sensitive to dys-regulation that then leads to accelerated loss of
follicles and oocytes from the ovary. Further research into this
environmentally induced epigenetic transgenerational inheritance
model is needed to determine the specific etiologies of adult onset
ovarian diseases.
Molecular Etiology of Transgenerational Adult Onset
Ovarian Disease
All the environmental exposures used in the current study
induced transgenerational ovarian abnormalities. From among
these exposures vinclozolin was used as a toxicant to study the
molecular changes occurring transgenerationally in granulosa
cells. Although all ovarian cell types (e.g. oocytes) are anticipated
to develop a transgenerational alteration in the transcriptome and
epigenome, granulosa cells were selected to provide the proof of
concept for this phenomena. Vinclozolin is an agricultural
fungicide with anti-androgenic endocrine disrupting activity [94].
Several studies have shown transgenerational effects following
exposure of gestating rats during the period of fetal gonadal sex
determination to vinclozolin [13]. These effects in the F3
generation animals include increased incidence of adult onset
diseases such as cancer, kidney disease, immune abnormalities,
prostate disease, spermatogenic defects and infertility
[20,75,78,95,96]. F3 generation female rats after ancestral
vinclozolin exposure have been shown to have uterine bleeding
abnormalities late in pregnancy [75]. The molecular mechanism
Figure 7. Ovarian diseases associated differentially expressed genes between F3 generation vinclozolin and control lineage
granulosa cell. Sub-networks were identified using global literature analysis with Pathway Studio
TM. Node and arrow code is the same as for
Figure 6. A: General ovarian diseases associated genes. B: Polycystic ovarian disease associated genes. White color nodes indicate differential
methylated regions identified in this study.
doi:10.1371/journal.pone.0036129.g007
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PLoS ONE | www.plosone.org 10 May 2012 | Volume 7 | Issue 5 | e36129involved in epigenetic transgenerational inheritance requires an
epigenetic alteration in the germline (egg or sperm) to transmit the
phenotype [13]. An environmental exposure during fetal gonad
sex determination appears to be required due to the epigenetic
programming of primordial germ cells during this developmental
period. Previous research with vinclozolin lineage rats has shown
that permanent alterations in the male germ line epigenome are
transmitted to subsequent generations and do not get erased after
fertilization during early embryonic development, in a manner
similar to imprinted genes [16]. A recent study demonstrates all
the exposures used in the current study promote exposure specific
epigenetic transgenerational alterations in the sperm epigenome
[19]. Since the altered base-line epigenome of the sperm promotes
an altered epigenome in cells and tissues that develop from that
sperm, all tissues, including the ovary, are anticipated to have
altered genome activity and develop a susceptibility to develop
disease [76].
In the current study granulosa cells from large antral follicles of
F3 generation females were evaluated for differences in either the
gene expression profile or the epigenetic pattern of vinclozolin-
lineage granulosa compared to controls. The gene expression of
granulosa cells from F3 generation vinclozolin and control lineage
animals was evaluated by microarray analysis. More than 500
genes were found to be differentially expressed compared to
controls (Table S1). This is a transgenerational effect of the
environmental compound exposure. The altered gene expression
profile of vinclozolin lineage granulosa cells could contribute to the
adult-onset development of abnormalities such as primary ovarian
insufficiency or polycystic ovarian disease. Bioinformatic analysis
of the differentially expressed gene list indicated that certain well-
characterized cellular pathways and processes could be affected by
changes in these genes (Table 1, Figure S2a, S2b). Interestingly,
many genes involved in lipid metabolism and steroid precursor
synthesis had altered expression, and this has been shown to
potentially be involved in the pathology of polycystic ovarian
disease [43]. Analysis of genes present within the 523 differentially
expressed gene set that have previously been correlated to ovarian
disease revealed 30 genes, Figure 7. In addition, 5 genes have been
shown to be directly correlated to polycystic ovarian disease.
Therefore, the current study involving an environmental toxicant
induced epigenetic transgenerational inheritance of adult onset
ovarian disease also identified a number of genes previously shown
to be associated with ovarian disease. A previous study compared
the transcriptomes of cumulus granulosa cells from human PCOS
patients and normal control women after culturing the cumulus
cells. Similarly to the current study, genes in the MAPK signaling
pathway and in extracellular matrix/cell adhesion were found to
be affected. However, few specific differentially expressed genes
were found in common with the current study [97].
A gene network analysis of the transgenerationally altered
granulosa cell transcriptome generated a highly connected set of
potential regulatory genes (Fig. 6) associated with the ovarian
abnormalities identified. This regulatory gene network provides
potential new therapeutic targets and diagnostic markers to
consider in ovarian disease etiology. Critical gene targets for
future studies to be considered include Esr1, Esr2, Srebf2, Mmp2,
Cxcl12, Lpl, Stat5b and Hmgcr.
The F3 generation granulosa cell epigenome analysis of
differential DNA methylation demonstrated 43 different DMR
in promoters. The MeDIP-Chip analysis used a comparative
hybridization of F3 generation granulosa cell DNA for vinclozolin
versus control lineage animals to increase sensitivity. A promoter
tiling array Chip was used, so the majority of the genome was not
examined. Therefore, the 43 DMR identified in promoters are a
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PLoS ONE | www.plosone.org 11 May 2012 | Volume 7 | Issue 5 | e36129sub-set of the total epigenetic modifications possible. The
anticipation is a larger set of epigenetic modifications are present
genome wide. The 43 DMR identified in the F3 generation
granulosa cell epigenome demonstrates an environmental induced
transgenerational alteration that is correlated to the onset of
ovarian abnormalities. The DMR were present on most
autosomes. The CpG content of these DMR was 1–10 CpG per
100 bp. Previously, low density CpG regions have been shown to
be involved in epigenetic transgenerational alterations in sperm
[19,98]. This genomic feature is speculated to be important in the
epigenetic programming mechanism [19]. Interestingly, only one
DMR (Plekhm1) was present in the promoter of one of the
transgenerational 523 differentially expressed granulosa cell genes.
This is likely due to a random overlap. Therefore, a relatively low
number of epigenetic DMR sites could not explain the relatively
large number of differentially expressed genes observed. Direct
epigenetic regulation of individual promoters appears not to be
involved. The hypothesis developing is that the epigenetic
regulatory sites associated with the DMR may influence distal
gene expression through non-coding RNA and are termed
epigenetic control regions (ECR). This is similar on a molecular
level to the imprinting control regions (ICR) previously identified
(e.g. IGF2 and H19) [77]. The transgenerational differentially
expressed gene set of 523 genes was examined in regards to
chromosomal location and 26 gene clusters of 2–5 Mbase were
identified with a statistically significant (p,0.05) over-represented
set of genes, Figure 8 and Table S2. Several of these gene clusters
correlated to the location of a DMR (approximately 15%). In
addition, the small number (i.e. 20) of characterized rat long non-
coding RNA (lncRNA) had 3 sites that overlapped with the ECR,
but further characterization of the rat lncRNA’s is required before
functional associations between ECR and lncRNA can be
elucidated. Future studies will be needed to determine the
functional significance of these potential ECR sites, but the
current study suggests the potential presence of such sites. The
potential presence of DMR regulating such an ECR is speculated
to clarify how a limited number of alterations in the epigenome
may influence a large number of differentially expressed genes.
The molecular factors involved in epigenetic regulation of
genome activity (i.e. DNA methylation, histone modifications,
chromatin structure and non-coding RNA) can all regulate
proximal promoter activity and gene regulation. Epigenetic factors
such as DNA methylation, chromatin structure and non-coding
RNA can also regulate distal gene expression, independent of
classic genetic mechanisms. In the current study environmentally
induced transgenerational effects on the germ line promoted
epigenome and transcriptome effects in the granulosa cell that
correlate with adult onset ovarian abnormalities. The etiology of
ovarian diseases such as PCO and POI appear to in part involve:
1) environmental toxicant induced epigenetic alterations in the
germ-line (sperm) during fetal gonadal development; 2) permanent
alterations in the epigenome that are transmitted to subsequent
generations through the sperm; 3) induction of alterations in the
epigenome and transcriptome of all organs, such as the ovary, and
Figure 8. Chromosomal plot showing regions with vinclozolin-induced transgenerational changes in granulosa cells. Differential DNA
methylation regions are displayed as inverted red triangles, changes in gene expression are displayed as red ticks, and a significant gene cluster of
these genes with changed expression is delineated with blue open boxes. The chromosome number on Y-axis and size on X-axis are presented.
doi:10.1371/journal.pone.0036129.g008
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develop adult onset ovarian disease such as polycystic ovarian
disease or primary ovarian insufficiency. Although the current
study establishes the proof of concept such a mechanism exists, the
degree the environment and epigenetic transgenerational inheri-
tance is involved in human ovarian disease now needs to be
investigated. Future studies are needed to clarify the F1, F2 and F3
generation sperm epigenome alterations in relation to each other,
functional links of the DMR with the lncRNA and ECR, and to
characterize transgenerational developmental changes in the
transcriptome and epigenome of all ovarian cell types (e.g. oocyte,
granulosa and theca). Elucidation of these molecular processes and
mechanism will provide insights into the molecular etiology of
ovarian disease.
Summary
An outbred rodent rat model was used to investigate the
potential role of environmental epigenetics and epigenetic
transgenerational inheritance in the etiology of ovarian disease.
One of the ovarian abnormalities observed involved a decrease in
the ovarian follicle pool size which correlates with the biology of
primary ovarian insufficiency. The development of small and large
ovarian cysts and the morphology of the cysts correlates with the
biology of polycystic ovarian disease. However, these ovarian
diseases as defined in humans are broader in concept to include
correlated endocrine abnormalities and associated disease such as
insulin resistance and diabetes. Therefore, the current ovarian
abnormalities and disease in rats cannot be directly correlated to
the human polycystic ovarian syndrome (PCOS) nor human
primary ovarian insufficiency (POI) and loss of fertility. Although
the rat ovarian abnormalities are consistent with these disease
states, further research will be needed to clarify the role of
environmental epigenetics and epigenetic transgenerational inher-
itance of ovarian disease in humans. Elucidation of such a disease
etiology could help provide insight into clarifying the rapid
increase in incidence of ovarian disease and apparent environ-
mental impacts.
The environmental toxicants vinclozolin, dioxin and bisphenol-
A have been shown in previous research to have transgenerational
effects [21,22,75,78]. In recent research from our laboratory, all of
the environmental toxicants used in the current study were shown
to cause transgenerational disease in rats [19]. In the current study
DEHP and DBP were used in combination with bisphenol-A as a
single treatment, so it is uncertain if alone the compounds can
promote transgenerational disease in ovaries. Similarly, permeth-
rin was used in combination with DEET, so evidence suggests the
mixture can promote epigenetic transgenerational disease. The
hydrocarbon mixture jet fuel (JP8) also promoted a transgenera-
tional increase in the incidence of ovarian disease in these studies.
Results suggest that all these compounds should now be
considered as potentially able to promote transgenerational
ovarian disease.
The current study used pharmacologic doses of all the
compounds and mixtures based on approximately 1% of the oral
LD50 dose for most compounds, Table S3. The objective was to
determine if these exposures have the capacity to promote
epigenetic transgenerational inheritance of a disease phenotype,
and not to do risk assessment of the exposures. Now that the
current study has established the transgenerational actions of these
compounds, risk assessment toxicology involving dose curves of
relevant environmental doses are needed. In addition to consid-
ering the mode of administration and dose, the critical window of
exposure to promote the epigenetic transgenerational phenotype
(gonadal sex determination) needs to be considered, which for the
human is 6–18 weeks of gestation. The gestating women in the first
half of pregnancy would be the population most sensitive to
environmentally induced epigenetic transgenerational inheritance
of disease phenotypes.
In summary, gestating F0 generation rats were treated with
environmental toxicants transiently during fetal gonadal sex
determination. Adult-onset ovarian diseases resembling primary
ovarian insufficiency and polycystic ovarian disease were seen at
an increased rate in both the directly exposed offspring (F1), and
transgenerationally (F3). There was a significant transgenerational
alteration in both the transcriptome and the epigenome of
vinclozolin-lineage granulosa cells. Therefore, ancestral toxicant
exposure can contribute to the development of these disease states.
These results suggest a new paradigm be considered for the
etiology of ovarian disease. In addition to genetic abnormalities
being causative, epigenetic abnormalities can also cause changes in
gene expression during development that lead to these adult-onset
diseases. These epigenetic abnormalities can be induced by
exposure to a variety of environmental toxicants. If the exposure
occurs during a susceptible period of an animal’s development,
then these epigenetic abnormalities can be fixed into the germ line
(i.e. eggs or sperm) and be passed transgenerationally. Ovarian
disease such as PCO has impacts on other diseases such as diabetes
and adverse pregnancy outcomes [99]. Therefore, further
elucidation of the etiology of ovarian disease and potential role
of environmental epigenetics and epigenetic transgenerational
inheritance will provide insights into the prevention and thera-
peutic strategies for female health.
Methods
Animals and treatments
All experimental protocols involving rats were pre-approved by
the Washington State University Animal Care and Use Commit-
tee (IACUC approval # 02568-026). Hsd:Sprague Daw-
leyH
TMSDH
TM female and male rats of an outbred strain (Harlan)
were maintained in ventilated (up to 50 air exchanges/hour)
isolator cages (cages with dimensions of 10 L0W619 J0D610
L0H, 143 square inch floor space, fitted in Micro-vent 36-cage rat
racks; Allentown Inc., Allentown, NJ) containing Aspen Sani chips
(pinewood shavings from Harlan) as bedding, on a 14 h light: 10 h
dark regimen, at a temperature of 70 F and humidity of 25% to
35%. Rats were fed ad libitum with standard rat diet (8640 Teklad
22/5 Rodent Diet; Harlan) and ad libitum tap water for drinking.
At proestrus as determined by daily vaginal smears, the female
rats (90 days of age) were pair-mated with male rats (120 days). On
the next day, the pairs were separated and vaginal smears were
examined microscopically. If sperm were detected (day 0) the rats
were tentatively considered pregnant. Vaginal smears were
continued for monitoring diestrus status in these rats until day 7.
Pregnant rats were then given daily intraperitoneal injections of
any one of the following single chemicals or mixtures with an equal
volume of sesame oil (Sigma) on days E-8 through E-14 of
gestation [75], as seen in Table S3. Treatment groups were
Control (DMSO vehicle), Vinclozolin, Pesticide/repellent (in-
cludes: Permethrin (insecticide) and DEET (insect repellent)),
Plastics (Bisphenol-A, DBP and DEHP), Low-dose plastics, Dioxin
(TCDD), and Jet Fuel (JP8 hydrocarbon). The pregnant female
rats treated with various mixtures were designated as the F0
generation. A drop in litter size was noted in the F1 generation of
the Plastics group, so another treatment group was included with
only half the dose of Bisphenol-A, DBP and DEHP and this group
was designated the ‘Low Dose Plastics’ group. Doses, percent of
oral LD50, and sources of the compounds are given in Table S3.
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The offspring of the F0 generation were the F1 generation. The
F1 generation offspring were bred to other F1 animals of the same
treatment group to generate an F2 generation and then F2
generation animals bred similarly to generate the F3 generation
animals. No sibling or cousin breedings were performed so as to
avoid inbreeding. Note that only the original F0 generation
pregnant females were injected with the treatment compounds.
Evaluation of adult ovaries
Ovaries taken from rats at the time of sacrifice (one year of age)
were fixed in Bouin’s solution, paraffin embedded and sectioned at
5 mm thickness. Every 30
th section was collected and hematoxylin/
eosin stained. The three stained sections (150 mm apart) through
the central portion of the ovary with the largest cross-section were
evaluated microscopically for number of primordial follicles,
developing pre-antral follicles, small antral follicles, large antral
follicles, small cystic structures and large cysts. The mean number
of each evaluated structure per section was calculated across the
three sections. Follicles had to be non-atretic and have the oocyte
nucleus visible in the section in order to be counted. Atretic
follicles have granulosa cells or oocytes with pyknotic nuclei, an
uneven or reduced layer of granulosa cells, and/or an uneven and
less distinct basement membrane. Primordial follicles are in an
arrested state and have an oocyte surrounded by a single layer of
either squamous or both squamous and cuboidal granulosa cells
[100,101]. Normally a few primordial follicles at a time will
undergo primordial to primary follicle transition and become
developing follicles. Developing pre-antral follicles had one or
more complete layers of cuboidal granulosa cells. Small antral
follicles had a fluid-filled antrum and a maximum diameter of
510 mm measured across the outermost granulosa cell layer. Large
antral follicles had a diameter greater than 510 mm. Large antral
follicles may eventually ovulate. Cysts were defined as fluid-filled
structures of a specified size that were not filled with red blood cells
and which were not follicular antra. A single layer of cells may line
cysts. Small cysts were 50–250 mm in diameter measured from the
inner cellular boundary across the longest axis. Large cysts were
greater than 250 mm in diameter.
Neonatal rat ovary culture
Four-day old female Sprague-Dawley rats (Harlan Laboratories,
Inc., USA) were euthanized according to Washington State
University IACUC approved protocols and their ovaries removed
and cultured whole as described previously [102]. Four-day old rat
ovaries contain follicles that are almost exclusively of the
primordial stage. Whole ovaries were cultured on floating filters
(0.4 mm Millicell-CM, Millipore, Bedford, MD, USA) in 0.5 ml
Dulbecco’s modified Eagle’s medium (DMEM)-Ham’s F-12
medium (1:1, vol/vol) containing 0.1% BSA (Sigma), 0.1%
Albumax (Gibco BRL, Gaithersburg, MD, USA), 27.5 mg/ml
transferrin, and 0.05 mg/ml L-ascorbic acid (Sigma) in a four-well
culture plate (Nunc plate, Applied Scientific, South San Francisco,
CA, USA) for ten days. Previous studies have shown that four-day-
old ovaries cultured for ten days have good cell viability [103]. The
medium was supplemented with penicillin and streptomycin to
prevent bacterial contamination. Ovaries were randomly assigned
to treatment groups, with 1–3 ovaries per floating filter per well.
Culture medium was changed and wells were treated every two
days with vinclozolin (50 mM, 100 mM, 200 mM, or 500 mM), or
were treated with 0.1% DMSO as a vehicle control. After culture,
ovaries were fixed in Bouin’s fixative (Sigma) for two hours and
then equilibrated in 70% ethanol. Ovaries were then embedded in
paraffin, sectioned at 3 mm and stained with hematoxylin/eosin
for use in morphological analysis.
For each ovary the number of oocytes per section was counted
and the counts were averaged across the two consecutive
histological sections that had the largest ovarian cross section.
The oocyte nucleus had to be visible for an oocyte to be counted.
Normally, between 50 and 150 follicles were present in each cross-
section.
Blood samples were collected, allowed to clot, centrifuged and
serum samples stored for hormone assays. The androstenedione
levels in serum were determined with a radio-immunoassay (RIA)
performed by the Center for Reproductive Biology Assay Core at
Washington State University.
Super-ovulation and collection of granulosa cells
F3 generation rats from both vinclozolin-treated and control
lineages were treated with Pregnant Mare Serum Gonadotropin
(Sigma cat, St. Louis, MO)(30 IU PMSG injected IP) at five to six
months of age. Two days later animals were sacrificed and ovaries
removed. The ovarian bursa and its adherent fat was removed
from each ovary and the ovaries processed for granulosa cell
collection [104]. The ovaries were suspended in the base medium
used for all procedures was Ham’s F-12 (Thermo Scientific).
Following sequential 30 minute incubations at 37 uCi n6m M
EGTA in F-12 (to decrease Ca
2+ - mediated cell adhesion) and
then 0.5 M sucrose in F-12 (to increase osmotic pressure within
follicles), ovaries were returned to F-12. Granulosa cells were
released into the medium from antral follicles using 30-gauge
needles and gentle pressure. Oocytes were removed by aspiration
under a dissecting microscope. Granulosa cells from each rat were
collected into 1.5 mL tubes, allowed to settle for 10 minutes and
supernatant removed. 1.0 mL of Trizol
TM (Invitrogen) was added
to each sample, and then samples were stored at 270u until the
time of RNA and DNA isolation.
Microarray transcriptome analysis
Messenger RNA was isolated from Trizol
TM for each animal as
per manufacturers protocol. Messenger RNA from four animals of
the same treatment group were pooled to create three different
pooled samples from each of the two treatment groups. The
mRNA processing and hybridization were performed at the
Genomics Core Laboratory, Center for Reproductive Biology,
Washington State University, Pullman, WA using standard
Affymetrix reagents and protocol. Briefly, mRNA was transcribed
into cDNA with random primers, then cRNA was transcribed
from the cDNA, and from that, single-stranded sense DNA was
synthesized which was fragmented and labeled with biotin. Biotin-
labeled fragmented ssDNA was then hybridized to the Rat Gene
1.0 ST microarrays containing more than 27,000 transcripts
(Affymetrix, Santa Clara, CA, USA). Hybridized chips were
scanned on an Affymetrix Scanner 3000. CEL files containing raw
data were then pre-processed and analyzed with Partek Genomic
Suite 6.5 beta software (Partek Incorporated, St. Louis, MO) using
an RMA and GC-content adjusted algorithm (Figure S1). The
signals from an average of 28 different probes for each transcript
were compared to give a single value. Lists of differentially
expressed genes for each treatment were generated using the
following cut off criteria: signal ratio Treatment/Control .1.20
change, mean difference for un-logged signals between control and
treatment .10, t-test p-values,0.05 using an analysis correcting
for organ culture date batch effects.
CEL files from this study have been deposited with the NCBI
gene expression and hybridization array data repository (GEO,
http://www.ncbi.nlm.nih.gov/geo, #GSE 33423) and can be also
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Affymetrix annotation file RaGene1_0stv1.na31.rn4.transcript.csv
was used unless otherwise specified.
To look for known functional relationships among the F3
generation differentially expressed genes identified above, KEGG
pathways were interrogated using the http://www.genome.jp/
kegg/ website (Kyoto Encyclopedia for Genes and Genome,
Kyoto University, Japan), and also using Pathway Express, a web-
based tool freely available as part of the Onto-Tools website
(http://vortex.cs.wayne.edu) [105].
To further look for known functional relationships among the
F3 differentially expressed genes, an unbiased, automated survey
of published literature was performed to determine which genes
are functionally linked with respect to binding, up-regulation,
down-regulation, etc. Global literature analysis of differentially
expressed genes was performed using Pathway Studio software
(Ariadne, Genomics Inc. Rockville MD), which performs an
interaction analysis and builds sub-networks of genes and the
cellular processes that connect them to each other.
Previous studies have demonstrated that microarray data are
validated with quantitative PCR data [106,107]. Due to the
presence of an average of 28 different oligonucleotide probes for
each specific gene being used on the microarray versus only a
single primer set for a gene in a quantitative PCR, the microarray
is more effective at eliminating false positive or negative data and
provides a more robust quantification of changes in gene
expression.
Methylated DNA immunoprecipitation (MeDIP)
DNA was collected from the same granulosa cell Trizol
TM
preparations that were used for RNA isolation. The DNA
Trizol
TM fractions from four animals of the same treatment group
were pooled to create three different pooled DNA samples from
each of the two treatment groups. These DNA samples were then
used for methylated DNA immunoprecipitation (MeDIP). MeDIP
was performed as follows: 6 mg of genomic DNA was subjected to
series of three 20 pulse sonications at 20% amplitude and the
appropriate fragment size (200–1000 bp) was verified through 2%
agarose gels; the sonicated genomic DNA was resuspended in
350 ml TE and denatured for 10 min at 95uC and then
immediately placed on ice for 5 min; 100 mlo f5 6 IP buffer
(50 mM Na-phosphate pH7, 700 mM NaCl, 0.25% Triton X-
100) was added to the sonicated and denatured DNA. An
overnight incubation of the DNA was performed with 5 mgo f
antibody anti-5-methylCytidine monoclonal from Diagenode S.A
(Denville, NJ) at 4uC on a rotating platform. Protein A/G beads
from Santa Cruz (Santa Cruz, CA) were prewashed on PBS-BSA
0.1% and resuspended in 40 ml1 6 IP buffer. Beads were then
added to the DNA-antibody complex and incubated 2 h at 4uCo n
a rotating platform. Beads bound to DNA-antibody complex were
washed 3 times with 1 ml 16 IP buffer; washes included
incubation for 5 min at 4uC on a rotating platform and then
centrifugation at 6000 rpm for 2 min. Beads-DNA-antibody
complex were then resuspended in 250 ml digestion buffer
(50 mM Tris HCl pH 8, 10 mM EDTA, 0.5% SDS) and 3.5 ml
of proteinase K (20 mg/ml) was added to each sample and then
incubated overnight at 55uC on a rotating platform. DNA
purification was performed first with phenol and then with
chloroform:isoamyl alcohol. Two washes were then performed
with 70% ethanol, 1 M NaCl and glycogen. MeDIP selected DNA
was then resuspended in 30 ml TE buffer. Whole-genome
amplification was then performed with the WGA2 kit (Sigma-
Aldrich #WGA2) on each MeDIP sample to be used in the
microarray comparative hybridization analysis.
Tiling Array MeDIP-Chip Analysis
Roche Nimblegen’s Rat DNA Methylation 3x720K CpG Island
Plus RefSeq Promoter Array was used, which contains three
identical sub-arrays, with 713,670 probes per sub-array, scanning
a total of 15,287 promoters (3,880 bp upstream and 970 bp
downstream from transcription start site). Probe sizes range from
50–75 mer in length with a median probe spacing of 100 bp.
Three different comparative (amplified MeDIP vs. amplified
MeDIP) hybridizations experiments (3 sub-arrays) were per-
formed, each encompassing DNA samples from 24 animals (3
treatment and 3 control groups). MeDIP DNA samples from
experimental groups were labeled with Cy3 and MeDIP DNA
samples from the control groups were labeled with Cy5.
Bioinformatic and Statistical Analyses of Chip Data
For each comparative hybridization experiment, raw data from
both the Cy3 and Cy5 channels were imported into R (R
Development Core Team (2010), R: A language for statistical
computing, R Foundation for Statistical Computing, Vienna,
Austria. ISBN 3-900051-07-0, URL http://www.R-project.org),
checked for quality and converted to MA values (M=Cy52Cy3;
A=(Cy5+Cy3)/2). The following normalization procedure was
conducted. Within each array, probes were separated into groups
by GC content and each group was separately normalized,
between Cy3 and Cy5 using the loess normalization procedure.
This allowed for GC groups to receive a normalization curve
specific to that group. After each array had its CG groups
normalized within the array, the arrays were then normalized
across arrays using the A quantile normalization procedure.
Following normalization each probe within each array was
subjected to a smoothing procedure, whereby the probe’s
normalized M values were replaced with the median value of all
probe normalized M values across all arrays within a 600 bp
window. If the number of probes present in the window was less
than 3, no value was assigned to that probe. Each probe’s A values
were likewise smoothened using the same procedure. Following
normalization and smoothing each probe’s M value represents the
median intensity difference between vinclozolin generation and
control generation of a 600 bp window. Significance was assigned
to probe differences between treatment-generation samples and
control generation samples by calculating the median value of the
intensity differences as compared to a normal distribution scaled to
the experimental mean and standard deviation of the normalized
M. A Z-score and P-value were computed for each probe from
that distribution. The statistical analysis was performed in pairs of
comparative IP hybridizations between treatment lineage (T) and
control lineage (C). T1-C1 and T2-C2 gave 333 sites; T1-C1 and
T3-C3 gave 327 sites; T2-C2 and T3-C3 gave 340 sites. In order
to assure the reproducibility of the candidates obtained, only the
candidates showing significant changes in all three of the paired
comparisons were chosen as having a significant change in DNA
methylation between the experimental group and controls. This is
a very stringent approach to select for changes, since it only
considers those changes repeated in all paired analyses.
Clustered Regions of interest were then determined by
combining consecutive probes within 600 bases of each other,
and based on whether their mean M values were positive or
negative, with significance p-values less than 10
25. The statistically
significant differential DNA methylated regions were identified
and P-value associated with each region presented. Each region of
interest was then annotated for gene and CpG content. This list
was further reduced to those regions with an average intensity
value exceeding 9.5 (log scale) and a CpG density $1 CpG/
100 bp.
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Treatment groups are compared using analysis of variance
(ANOVA) followed by Dunnet’s post-hoc tests where appropriate.
Groups were considered statistically significant with P#0.05.
Statistics for ovary counts were calculated using Graph Pad Prism
version 5.0 b for Macintosh, Graph Pad Software, San Diego, CA,
USA.
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Figure S1 Sample histograms and box plots for granu-
losa cell microarray signal values after pre-processing
with RMA, GC-content adjusted algorithm. Plots for F3
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microarrays.
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Figure S2 (A): Steroid Biosynthesis Pathway; and (B):
PPAR Signaling Pathway showing granulosa cell differ-
entially expressed genes between F3 generation vinclo-
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boxes represent up-regulated genes, green down-regu-
lated and white boxes – not affected genes.
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Table S1 Rat granulosa cell genes differentially ex-
pressed between F3 generation vinclozolin and control
lineage animals (523 genes).
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Table S2 Differential expressed gene clusters.
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